Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 14

1.

Link between type 2 diabetes and Alzheimer's disease: from epidemiology to mechanism and treatment.

Li X, Song D, Leng SX.

Clin Interv Aging. 2015 Mar 10;10:549-60. doi: 10.2147/CIA.S74042. eCollection 2015. Review.

2.

Impact of aerobic exercise on neurobehavioral outcomes.

Smith PJ, Potter GG, McLaren ME, Blumenthal JA.

Ment Health Phys Act. 2013 Oct;6(3):139-153.

3.

Plasma vitamin D levels and cognitive function in aging women: the nurses' health study.

Bartali B, Devore E, Grodstein F, Kang JH.

J Nutr Health Aging. 2014 Apr;18(4):400-6. doi: 10.1007/s12603-013-0409-9.

4.

Can lifestyle modification improve neurocognition? Rationale and design of the ENLIGHTEN clinical trial.

Blumenthal JA, Smith PJ, Welsh-Bohmer K, Babyak MA, Browndyke J, Lin PH, Doraiswamy PM, Burke J, Kraus W, Hinderliter A, Sherwood A.

Contemp Clin Trials. 2013 Jan;34(1):60-9. doi: 10.1016/j.cct.2012.09.004. Epub 2012 Sep 19.

5.

Midlife obesity and trajectories of brain volume changes in older adults.

Driscoll I, Beydoun MA, An Y, Davatzikos C, Ferrucci L, Zonderman AB, Resnick SM.

Hum Brain Mapp. 2012 Sep;33(9):2204-10. doi: 10.1002/hbm.21353. Epub 2011 Aug 30.

6.

Fasting plasma insulin, C-peptide and cognitive change in older men without diabetes: results from the Physicians' Health Study II.

Okereke OI, Kurth T, Pollak MN, Gaziano JM, Grodstein F.

Neuroepidemiology. 2010;34(4):200-7. doi: 10.1159/000289351. Epub 2010 Mar 3.

7.

Physical activity levels and cognition in women with type 2 diabetes.

Devore EE, Kang JH, Okereke O, Grodstein F.

Am J Epidemiol. 2009 Oct 15;170(8):1040-7. doi: 10.1093/aje/kwp224. Epub 2009 Sep 3.

8.

Adiposity, type 2 diabetes, and Alzheimer's disease.

Luchsinger JA, Gustafson DR.

J Alzheimers Dis. 2009;16(4):693-704. doi: 10.3233/JAD-2009-1022. Review.

9.

Dietary fat intake and cognitive decline in women with type 2 diabetes.

Devore EE, Stampfer MJ, Breteler MM, Rosner B, Kang JH, Okereke O, Hu FB, Grodstein F.

Diabetes Care. 2009 Apr;32(4):635-40. doi: 10.2337/dc08-1741.

10.

A profile of impaired insulin degradation in relation to late-life cognitive decline: a preliminary investigation.

Okereke OI, Selkoe DJ, Pollak MN, Stampfer MJ, Hu FB, Hankinson SE, Grodstein F.

Int J Geriatr Psychiatry. 2009 Feb;24(2):177-82. doi: 10.1002/gps.2089.

11.

Fasting insulin levels and cognitive decline in older women without diabetes.

van Oijen M, Okereke OI, Kang JH, Pollak MN, Hu FB, Hankinson SE, Grodstein F.

Neuroepidemiology. 2008;30(3):174-9. doi: 10.1159/000126909. Epub 2008 Apr 17.

12.

Adiposity, hyperinsulinemia, diabetes and Alzheimer's disease: an epidemiological perspective.

Luchsinger JA.

Eur J Pharmacol. 2008 May 6;585(1):119-29. doi: 10.1016/j.ejphar.2008.02.048. Epub 2008 Mar 4. Review.

13.

Plasma C-peptide levels and rates of cognitive decline in older, community-dwelling women without diabetes.

Okereke OI, Pollak MN, Hu FB, Hankinson SE, Selkoe DJ, Grodstein F.

Psychoneuroendocrinology. 2008 May;33(4):455-61. doi: 10.1016/j.psyneuen.2008.01.002. Epub 2008 Feb 7.

14.

Adiposity and Alzheimer's disease.

Luchsinger JA, Mayeux R.

Curr Alzheimer Res. 2007 Apr;4(2):127-34. Review.

Items per page

Supplemental Content

Write to the Help Desk